LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)
$0 None (None%)
Analysed LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) News Sources
RBC Cuts Galapagos NV (GLPG) Price Target to $28, Maintains Sector Perform Ahead of Q1
24-04-2026
yahoo.com
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
28-04-2026
yahoo.com
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
06-05-2026
yahoo.com
Galapagos Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
10-08-2026
yahoo.com
Lakefront Receives Transparency Notification from Bank of America
24-08-2026
yahoo.com
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
24-08-2026
yahoo.com
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board
04-09-2026
yahoo.com
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08-09-2026
yahoo.com
Acquisition of Own Shares
15-09-2026
yahoo.com
What is the current price of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)?
The current price of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) is $0.
LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) since the previous trading day is $None.
LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)?
The most recent average sentiment score for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) is 60 out of 100.
What is the most recent average sentiment for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)?
The most recent sentiment for LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS) is .
SEC-8K** Filing Available For LAKEFRONT BIOTHERAPEUTICS (GLPGF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.